These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27354678)

  • 1. Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.
    LeGresley E; Lee K
    Tob Control; 2017 May; 26(3):316-322. PubMed ID: 27354678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big tobacco is watching: British American Tobacco's surveillance and information concealment at the Guildford depository.
    Muggli ME; LeGresley EM; Hurt RD
    Lancet; 2004 May; 363(9423):1812-9. PubMed ID: 15172782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transparency as a remedy against racketeering: preventing and restraining fraud by exposing Big Tobacco's dirty secrets.
    Muggli ME; Crystal HM; Klausner K
    Tob Control; 2015 Sep; 24(5):514-8. PubMed ID: 25052863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco industry documents: comparing the Minnesota Depository and internet access.
    Balbach ED; Gasior RJ; Barbeau EM
    Tob Control; 2002 Mar; 11(1):68-72. PubMed ID: 11891371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the corporate documents of British American Tobacco: an invaluable global resource needs radically improved access.
    Collin J; Lee K; Gilmore AB
    Lancet; 2004 May; 363(9423):1746-7. PubMed ID: 15172767
    [No Abstract]   [Full Text] [Related]  

  • 6. Movie moguls: British American Tobacco's covert strategy to promote cigarettes in Eastern Europe.
    LeGresley EM; Muggli ME; Hurt RD
    Eur J Public Health; 2006 Oct; 16(5):505-8. PubMed ID: 16601109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco industry lawyers as "disease vectors".
    Guardino SD; Daynard RA
    Tob Control; 2007 Aug; 16(4):224-8. PubMed ID: 17652236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
    Hammond D; Chaiton M; Lee A; Collishaw N
    CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competing with kreteks: transnational tobacco companies, globalisation, and Indonesia.
    Lawrence S; Collin J
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii96-103. PubMed ID: 15564227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking and re-entering: British American Tobacco in China 1979-2000.
    Lee K; Gilmore AB; Collin J
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii88-95. PubMed ID: 15564226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open doorway to truth: legacy of the Minnesota tobacco trial.
    Hurt RD; Ebbert JO; Muggli ME; Lockhart NJ; Robertson CR
    Mayo Clin Proc; 2009 May; 84(5):446-56. PubMed ID: 19411441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Key to the future": British American tobacco and cigarette smuggling in China.
    Lee K; Collin J
    PLoS Med; 2006 Jul; 3(7):e228. PubMed ID: 16834455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. British American Tobacco's failure in Turkey.
    Lawrence S
    Tob Control; 2009 Feb; 18(1):22-8. PubMed ID: 18845622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British American Tobacco's tactics during China's accession to the World Trade Organization.
    Zhong F; Yano E
    Tob Control; 2007 Apr; 16(2):133-7. PubMed ID: 17400952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.
    Tan CE; Kyriss T; Glantz SA
    PLoS Med; 2013; 10(5):e1001450. PubMed ID: 23723740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
    Muggli ME; Lee K; Gan Q; Ebbert JO; Hurt RD
    PLoS Med; 2008 Dec; 5(12):1729-69. PubMed ID: 19108603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.
    Velicer C; Lempert LK; Glantz S
    Tob Control; 2015 Sep; 24(5):469-80. PubMed ID: 24920577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.
    Iida K; Proctor RN
    Lancet; 2004 May; 363(9423):1820-4. PubMed ID: 15172783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.